Our governance model includes: Prescribing restricted to Dr Nirusha Kumaran and Dr Tasnim Elghandy, both holding valid certification in peptide therapy Quarterly clinical audit of outcomes, adverse events, and adherence Documented discontinuation criteria for every active protocol An active adverse event registry and clinical KPI tracking No prescribing in cases of active malignancy, pregnancy, or severe psychiatric illness This level of institutional rigour is what separates physician-led peptide therapy from the commercially driven, under-regulated alternatives that exist elsewhere in the market
For professionals interested in staying current with peptide research developments, following these emerging directions provides valuable insights into the future therapeutic landscape
Spiga L, Fansler RT, Perera YR, Shealy NG, Munneke MJ, David HE, et al
From there, the peptide circulates throughout the body, reaching joints, tendons, and nerves that need repair
Barnacle Boy: You're Mermaid Man, you old coot